Genascence Names Ian Lachlan McLean, M.D. Ph.D. as Chief Medical Officer

—Seasoned physician-scientist and R&D executive, with significant experience building and growing successful clinical development organizations— PALO ALTO, Calif., Oct. 18, 2023 /PRNewswire/ — Genascence Corporation (“Genascence”), a clinical-stage biotechnology company revolutionizing…

Click here to view original post